Seoul, South Korea

Hye Young Suh

This inventor holds 1 USPTO granted patent. Top assignee: Samsung Bioepis Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hye Young Suh. Retrieved from https://idiyas.com/inventor/hye-young-suh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Introduction

Hye Young Suh is a distinguished inventor based in Seoul, South Korea. With a focus on biotechnological advancements, he has made significant contributions to the field of polypeptide production.

Latest Patents

Hye Young Suh holds a patent for a novel method for producing polypeptides using PDK-inactivated cells. This innovative approach provides a recombinant cell that includes an inactivated pyruvate dehydrogenase kinase (PDK) gene. The patented invention also comprises a composition for producing a polypeptide of interest utilizing this recombinant cell, showcasing a groundbreaking method in the biopharmaceutical industry.

Career Highlights

He is currently employed at Samsung Bioepis Co., Ltd., a leading biotechnology company known for its work in developing biosimilars and innovative medicines. Hye Young's research and development efforts have significantly contributed to advancements in biotechnological applications.

Collaborations

In his career, Hye Young has worked alongside notable colleagues, including Eunyoung Park and Hee Kyung Sung. Together, they have collaborated on various projects aimed at enhancing the efficiency and efficacy of polypeptide production methods.

Conclusion

Hye Young Suh's pioneering work in the realm of polypeptides represents a valuable contribution to biomedicine. Through his innovative patent and collaboration with esteemed professionals, he continues to influence the landscape of biotechnology and drive forward the development of new therapeutic products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…